Share

January 08, 2019; 92 (2) Editorial

ECG monitoring after acute ischemic stroke

Does patient selection matter?

Mira Katan, Steven A. Lubitz
First published December 7, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006719
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
143

Share

Article Information

vol. 92 no. 2 65-66
DOI: 
https://doi.org/10.1212/WNL.0000000000006719
PubMed: 
30530795
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published December 7, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Mira Katan, MD, MS and
    2. Steven A. Lubitz, MD, MPH
  1. Mira Katan, MD, MS and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker Honoraria for presentation of data of the COSMOS study (Clinical Trials. gov number, NCT00390962) from BRAHMS,Berlin 2009.

    Editorial Boards:

    1. STROKE, section editor, since 2017

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. I received within the last 9 years an unrestricted research grants from BRAHMS/ Thermo Fisher Scientific (in 2009).

    Research Support, Government Entities:

    1. I received within the last 5 years research grants from the Swiss National Science Foundation (PZ00P3_142422). Moreover I am receiving a career developing grant form the Spital-Pool of the University Hospital of Zurich (2017-2019)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. I received a transatlantic career award from the Fondation Leducq and support form the Swiss Heart Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Steven A. Lubitz, MD, MPH
    3. Scientific Advisory Boards:

    1. (1) 05/2016, 05/2017 Advisory BoardSt. Jude Medical / Abbott(2) 11/2017 Advisory BoardBristol-Myers Squibb

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) 02/2017ConsultantQuest Diagnostics

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Bristol Myers Squibb / Pfizer, (2) Bayer HealthCare(3) Boehringer Ingelheim(4) Biotronik

    Research Support, Government Entities:

    1. (1) NIH 1K23HL114724, 1R01HL139731

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) American Heart Association 18SFRN34250007(2) Doris Duke Charitable Foundation 2014105, 2016077, 2017039

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (M.K.), University Hospital of Zurich, Switzerland; and Cardiac Arrhythmia Service and Cardiovascular Research Center (S.A.L.), Massachusetts General Hospital, Boston.
  1. Correspondence
    Dr. Katan mira.katan{at}usz.ch
View Full Text

Article usage

Article usage: December 2018 to November 2019

AbstractFullPdfSource
Dec 2018291023Highwire
Jan 20193057348Highwire
Feb 201986149Highwire
Mar 20191471013Highwire
Apr 201917857Highwire
May 201910833Highwire
Jun 201910324Highwire
Jul 201912484Highwire
Aug 201910645Highwire
Sep 20198116Highwire
Oct 20198733Highwire
Nov 2019101118Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me